RDD1609 as a Treatment for Idiopathic Pruritus Ani
Status:
Unknown status
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
This is a double-blind, randomized, placebo-controlled, crossover trial, to test the
hypothesis that RDD1609 is effective in treating idiopathic pruritus ani.